Combined Compared to Sequential Cognitive and Physical Training in Anterior Cruciate Ligament Reconstructed Individuals
Launched by MICHELLE C. HAAS · Feb 19, 2025
Trial Information
Current as of July 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of training—combined cognitive and physical tasks versus single tasks—affect the performance of individuals who have had surgery to reconstruct their anterior cruciate ligament (ACL). The goal is to see if doing both types of training together (like solving puzzles while exercising) improves thinking and physical abilities compared to training them separately. Participants will engage in these training sessions twice a week for 10 weeks, and they will be evaluated before and after the training to measure any changes in their cognitive and physical performance.
To participate, individuals must be between 18 and 40 years old and at least six months post-surgery for their ACL injury. They should have been active in sports for at least two hours a week before their injury and must meet other health criteria, like not having recent surgery on the other leg or certain medical conditions. Participants will also have a chance to visit a movement lab to analyze how they move while training. This study is not yet recruiting, but it's an opportunity for eligible individuals to help researchers understand how different training methods can aid in recovery after ACL surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-40 years old
- • At least 6 months after ACL injury
- • Surgically reconstructed ACL
- • At least 2 hours of sports participation before the injury
- • Written consent of the attending surgeon to perform intensified training methods including one-legged jumps at 6 months after surgery after the first visit
- • Ability to give informed consent as documented by signature
- • Ability to understand instructions in German or English
- • BMI \< 28 kg/m\^2
- • Availability to take part in at least 70% of all training sessions
- Exclusion Criteria:
- • Surgery on the contralateral leg during the last 12 months
- • Acute or chronic musculoskeletal, neurological, or cardiopulmonary disorders
- • Unadjusted vision problems
- • Concussion during the last 6 months
- • Pregnancy
- • Breastfeeding
- • Amputation
- • Inflammatory pain or swelling during exercising
About Michelle C. Haas
Michelle C. Haas is a dedicated clinical trial sponsor with a robust commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies, she leads initiatives that enhance the efficiency and effectiveness of clinical trials across various therapeutic areas. Her expertise in regulatory compliance, trial design, and patient engagement ensures that studies are conducted with the highest standards of integrity and scientific rigor. Michelle's collaborative approach fosters strong partnerships with research institutions and healthcare professionals, driving progress in the development of new treatments and contributing to the overall advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winterthur, , Switzerland
Winterthur, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported